Trial Details

UNKNOWN
Basic Information
Clinical ID c1779
Identifier NCT01632462
Trial Title A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn's Disease
Interventions DRUG: VSL#3
Participant Information
Sponsor Federico II University
City Naples
Country/Region Italy
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-09-12
Primary Completion Date 2025-12-14
Completion Date 2025-02-15